The FDA has made available background materials and webcast information for the advisory committee meeting to review eteplirsen on Monday, April 25.
To view the complete set of background information including a meeting agenda, meeting roster, committee roster and briefing information, visit 2016 Meeting Materials, Peripheral and Central Nervous System Drugs Advisory Committee.
The Center for Drug Evaluation and Research (CDER) plans to provide a free of charge, live webcast of the meeting, beginning at approximately 8 a.m. ET. The webcast will be archived and posted following the meeting.
View the live webcast here, or copy the following URL into your browser: http://fda.yorkcast.com/webcast/Play/a6b3b94c459a4dcbb617a954382d678a1d.